Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia

Prophylactic low molecular weight heparin (pLMWH) is currently recommended in COVID-19 to reduce the risk of coagulopathy. The aim of this study was to evaluate whether the antinflammatory effects of pLMWH could translate in lower rate of clinical progression in patients with COVID-19 pneumonia. Pat...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Sci Rep
मुख्य लेखकों: Vergori, Alessandra, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Donno, Davide Roberto, Gualano, Gina, Nicastri, Emanuele, Iacomi, Fabio, Marchioni, Luisa, Campioni, Paolo, Schininà, Vincenzo, Cicalini, Stefania, Agrati, Chiara, Capobianchi, Maria Rosaria, Girardi, Enrico, Ippolito, Giuseppe, Vaia, Francesco, Petrosillo, Nicola, Antinori, Andrea, Taglietti, Fabrizio
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group UK 2021
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167179/
https://ncbi.nlm.nih.gov/pubmed/34059708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-90713-6
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन